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Introduction
            Syncope is a sudden transient loss of consciousness with loss of postural tone, followed
by spontaneous recovery1.  Around 30 percent of the general population have one syncopal event
in  their  lifetime,  with  3%  having  recurrent  episodes2.  Vasovagal  syncope  (VVS)  is  an
exaggerated tendency towards the common faint that accounts for up to 29% of syncope3 and
affects  all  age  groups.  VVS  is  characterised  by  profound  hypotension  with  or  without
bradycardia.  Those  with  VVS  are  at  risk  of  injury  during  episodes  and  the  long  term
implications of recurrent episodes of hypotension are unclear1. The underlying pathophysiology
of VVS is uncertain and current treatments involve salt and fluid replacement and maintenance
of  blood  pressure  using  mineralocorticoids  or  alpha  agonists1.  These  treatments  are  largely
symptomatic and may be associated with side effects that make their use in younger age groups
inappropriate4.  
            VVS can  generally be  differentiated  from other  causes  of  syncope through clinical
evaluation.  A definitive diagnosis of VVS is made by Head-up Tilt Table (HUT) test with the
diagnosis of VVS being confirmed when a patient develops hypotension and/or bradycardia in
association with syncopal or presyncopal symptoms5. One of the main methodological threats to
current research into VVS is the appropriate measurement of VVS.  A HUT is the most sensitive
tool to diagnose VVS5.  The majority of studies however have recruited participants diagnosed
by medical evaluation and symptom pattern recognition only6,7,8,9,10.  Although this method of
diagnosis has some degree of reliability and validity, it is not as reliable as a diagnosis made by
HUT. 
            There can be a wide range of reported illness and disability associated with the same level
of disease11. The experience of VVS is at best inconvenient, and may be perceived as threatening
and disabling. 
            In this review we will consider the evidence that psychological factors play a role in the
development  and maintenance of the symptoms of syncope,  and more specifically vasovagal
syncope,  and  whether  psychological  interventions  might  impact  upon  the  manifestation  and
consequences of these symptoms. Research into the psychological factors in syncope has mainly
involved groups of participants who have syncope of mixed origin.  There are very few studies
that have focussed exclusively on VVS as a separate condition. Further, it is also important to
appreciate that there are no measures specific to VVS and that in many studies the diagnosis of
VVS is by clinical evaluation rather than by a positive diagnostic test, raising the question that all
that is syncopemay not be vasovagal in origin.  
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Psychological factors associated with syncope
1. Impact of syncope on reported quality of life
            Patients with frequent syncope have been shown to have a markedly reduced quality of
life, similar to that of patients with severe rheumatoid arthritis or chronic low back pain8,12. This
provides some indication of the significantly disabling nature of this condition
            Quality of life appears to decrease with increasing frequency of syncope, and there is
evidence of  impairment  in  all  reported dimensions  -  particularly in  terms  of  mobility, usual
activities, and self care13.  This impact upon quality of life is reversible and improves within six
months when the frequency of syncope is reduced, as exemplified when syncopal events are
reduced on permanent pacemaker implantation14.
            Linzer’s group have developed a disease specific measure of impairment due to recurrent
syncope (mixed aetiology)12.  This tool measures psychosocial impairment due to syncope and
has reported difficulties with activities of daily living (71%), driving (60%), physical activities
(56%), and even walking (42%).  Problems in relationships  with friends,  family and spouses
have also been noted.  Twenty one per cent of patients have a high degree of fear and worry
about their condition which is not associated with injury due to syncope.
2. Psychological reactions to syncope
            Patients with syncope have a high prevalence of psychological distress, especially anxiety
and depression6,8,15,16.  Individuals  may fear  their  syncope and the  negative  consequences  of
fainting and can be severely disabled by their condition17.
            Insights into thoughts immediately before syncope come from a study involving US Air
force active  flying personnel  who had experienced syncope9.  Thoughts  included predictions
about potential bodily or psychological harm, particularly people’s reactions to their action, fear
of others laughing at them, or being embarrassed due to being socially inappropriate. Virtually all
subjects reported that they felt helpless in avoiding the threatening situation.
            Vigilance of somatic symptoms linked with fainting, such as feeling hot and giddy, may
also sustain apprehension and fear about  fainting.  The autonomic symptoms of syncope and
anxiety are similar, so fear arousal may amplify the physiological signs associated with syncope
and lead to an increase in the fear associated with syncope18.  
Some studies suggest that co morbid diseases, number of syncopal events, duration of syncope
and injury due to syncope have no relationship to impairment due to syncope12. Psychological
factors may mediate impairment associated with syncope, and this would mirror findings in other
fields  of  chronic  disease,  for  example  chronic  pain19 and  angina20.  Studies  suggest6 that
psychiatric illness is more likely in females, younger age groups (as would be expected in the
general population), and in those with a higher number of previous syncopal events.
            Despite the methodological problems that make it difficult to draw definite conclusions
for these populations with VVS, there is a suggestion that the ways that people understand their
condition and their experience and then make predictions about the consequences of fainting is
associated with different styles of coping and adjustment, and subsequent quality of life. This
raises some interesting areas of potential psychological investigation. 
Psychological factors associated with vasovagal syncope
            Studies  specifically carried out  in those with VVS are few, and in those with VVS
diagnosed exclusively by HUT are rarer still.  It could be argued that it is not appropriate to
extrapolate  data  from  heterogeneous  groups  of  syncopal  patients  to  those  with  VVS.  Our
experience  would  support  the  fact  that  VVS can  lead  to  high  levels  of  illness  and  impact
profoundly upon the quality of life of the sufferer.  For example VVS is associated with school
absences in children and absence from work in adults4.
            Studies suggest that the measurement of psychological constructs in VVS is narrow and
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tend to focus on demonstrating there is psychological distress among VVS participants.  The
measures used however are not specific to VVS.  For example, McGrady et al 17 used the Beck
Depression Inventory (BDI) and the State Trait Anxiety Inventory (STAI).  These give a level of
depression and anxiety within the groups, but it does not allow for the question of cause or effect
to be resolved.
            One retrospective study16 has gathered data from medical notes around the emotional
impact of VVS and the reported stressful aspects of VVS.  Over half (56%) reported a history of
mood disturbance and twenty-one percent were taking a psychotropic medication. A range of
psychological problems were reported including suicidal ideation, but in particular depression,
panic and chronic anxiety.  This is in line with levels of emotional distress reported in other
groups with chronic disease. This study also found that patients often experience disabling and
uncomfortable  symptoms  that  persist  for  hours  or  days  after  an  episode  of  syncope.  The
symptoms  they reported  as  distressing  include  fatigue,  dizziness  and  dyspnoea.  Over  forty
percent were anxious, worried and frustrated by their situation. The thoughts reported by this
group  concerned  the  condition  becoming  worse,  transportation  problems  due  to  driving
restrictions, not being able to fulfil occupational or family roles, concern about mood swings,
interpersonal relationships and the impact of the condition on spouses.   
            The more frequently reported personality characteristics of these individuals were of
discipline,  motivation,  organisation,  perfectionism,  punctuality and  sensitivity.  In this  group,
those who struggled most to cope with their condition were those who tended to be somewhat
self-stressing in their personal style.
            The perceived negative consequences of fainting and assumptions of having little or no
control together may result in fear and avoidance or restriction of activity leads to an impact on
the individual’s  quality of life.  In anxiety disorder such as panic,  avoidance and other self-
protecting  behaviours  have  been  shown  to  reinforce  the  belief  that  particular  situations  are
dangerous and prevent the development of more adaptive ways of coping with the condition21. 
The potential role of psychological intervention in the treatment of VVS 
            Given the high prevalence of psychological dysfunction in those with syncope and VVS
and  the  role  of  illness-related  beliefs  and  predictions  in  this  condition,  psychological
interventions could potentially have a part  to  play in the management  of VVS. Indeed, case
reports have described the successful use of applied tension (the use of physical manoeuvres
such as muscle tensing) and cognitive behaviour therapy (CBT) in patients with VVS22,23,24,25,26.
            A recent case series of patients with a definite diagnosis of VVS (i.e. positive head up tilt
and  full  reproduction  of  symptoms),  in  whom  conventional  treatments  had  not  improved
symptoms showed that CBT (incorporating applied tension) resulted in dramatic improvements
in symptomatology, consultation behaviour and outcome.  In nine patients there were significant
reductions  in  syncopal  episodes  and  consultation  rates  post  CBT  intervention  with  clear
subjective improvements in quality of life and ability to return to work or school4.  The CBT
treatment  components  included  identifying  and  restructuring  unhelpful  beliefs;  addressing
maladaptive somatic attention; reducing avoidance of certain activities and situations; the use of
applied tension, and addressing idiosyncratic issues, for example, difficulties sleeping and coping
with reactions of others.
            Whether similar affects are seen in patients with milder symptoms of VVS is unclear. 
Likewise, whether psychological symptoms are present early in the natural history of the disease
or whether psychological symptoms develop as the symptoms become more entrenched requires
clarifying. 
            There  is  evolving evidence  that  the SSRI class  of  antidepressant  is  effective  in  the
treatment of VVS and the neurotransmitter  serotonin has been implicated in the aetiology of
VVS.  Serotonin  inhibits  central  neurons  that  regulate  sympathetic  activity  and  there  is  an
association between VVS and depression, in which serotonin is also involved28.  Further work is
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needed in order to clarify whether the effectiveness of SSRI in VVS is due to syncope recurrence
or whether it has affects upon the subjects’ mood and ability to cope with their symptoms 
  
Conclusions
            There  are  a  number  of  psychological  issues  that  appear  to  be  important  in  the
development  and maintenance  of disability and psychological  distress  associated  with VVS. 
Current research suggests there is a role for psychological intervention in addressing the distress
and  disability  caused  by  VVS.  Further  longitudinal  research  may  help  to  develop  the
understanding of the experience of adapting to and coping with VVS, and provide a valuable
insight into the long-term psychological consequences of having VVS. Researchers must aim to
study pure groups of patients with VVS and develop and use measures that are specific to VVS. 
This process has started with the development of a measure of impairment due to syncope8,12. 
More work is needed to identify and match effective interventions to those who might most
benefit. 
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